Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...

This growth is fueled by advancements in early diagnostics, a rising incidence of liver and bile duct disorders, and the ...

The FDA has granted Orphan Drug Designation to tovecimig (CTX-009) for the treatment of patients with biliary tract cancer ...

A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose ...

Scientists developed a molecular test that detected bile duct cancer with twice the sensitivity of the standard test.

A total of 20 patients were included in the safety run-in cohort and completed preliminary evaluation. Results demonstrated that Opamtistomig in combination with chemotherapy was generally well ...

A 58-year-old man in the United States died after delays in insurance approval allegedly prevented him from receiving a ...

It didn’t matter that Eric Tennant’s oncologist had recommended the medication to shrink his tumors. The patient’s health ...

Patients with primary biliary cholangitis (PBC) can use linerixibat to address cholestatic pruritus, which up to 89% of patients with PBC experience.

When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must determine whether the cause is cancer or a benign condition.

Tennant's case has since inspired a new bill, HB 4965, to benefit PEIA members. Under the legislation, if members are ...

The FDA has issued a safety alert for Tavneos, a medication used to treat a rare autoimmune disease, due to recent reports ...